LARCG Profile
LARCG

@larcg_org

Followers
242
Following
143
Media
19
Statuses
156

Latin American Renal Cancer Group Collaborative group aimed at renal cancer research. It is constituted by 42 centers from 8 countries in LA and Spain.

Joined April 2017
Don't wanna be here? Send us removal request.
@larcg_org
LARCG
1 year
Ideas claras y decisiones que magnifican la calidad humana “Fundación ALE”. C. de México. Un placer participar desde el LARCG junto a Carlos Castro, Lucila, Dr. Michael Jewett, Dr. Francisco Rodríguez y Dra. Bourlon. @IKCCorg, @AleAsociacion, @MichaelASJewett, @DrFRodriguezCov
1
2
5
@larcg_org
LARCG
1 year
Feliz de comenzar la pasantía como "Observership" en en uno de los centros más importantes del mundo en Investigación-Tratamiento y Enseñanza sobre el Cancer "Memorial de New York"
4
0
13
@DrDanielHeng
Daniel Heng
2 years
Proud of @MartinZarba for presenting this #IMDC study. More follow up and patients required but it does highlight the importance of VEGF inhibition in very favorable patients. They are the most sensitive. #hypothesisgenerating #ASCO24 @OncoAlert
@tompowles1
Tom Powles
2 years
The IMDC story continues with a new very favourable group (good risk with no visceral mets and 3yrs since surgery).All the pts did well but Ipi/nivo was least impressive. Modest numbers & patient selection confounding, but there are VEGF mono sensitive slow growing tumors #ASCO24
0
19
35
@Nolazco_JI
José Ignacio Nolazco, MD, MMSc
2 years
🎯Outstanding presentation and meaningful discussion on 'Controversies in Partial Nephrectomy' by Steven L. Chang, MD, MS at the LARCG meeting. @larcg_org #AUA2024 @AmerUrological
0
2
12
@larcg_org
LARCG
2 years
A new step in the short and rewarding path of LARCG. Thanks to everyone who has joined us. 10º Annual Meeting AUA San Antonio, TX. @FPuigvert, @MoffittNews, @SpiessPhilippe, @IKCCorg, @StenioZequi, @nolazcomd @DrFRodriguezCov @KidneyCancer
1
4
11
@TarikiMilena
Milena shizue Tariki
2 years
Wonderful job! Congrats to all Gu @LACOG_group team and @larcg_org . Special thanks to @SoaresAndrey and @StenioZequi
1
4
9
@larcg_org
LARCG
2 years
Huge paper by Mark Purdue (NIH/NCI). Grateful for the opportunity to collaborate from the LARCG and with the most prominent researchers in Renal Cancer. @theNCI, @larcg_org, @StenioZequi
1
1
6
@larcg_org
LARCG
2 years
Very grateful to the NCCN for the great opportunity to participate as an international reviewer in the Renal Cancer guidelines. @NCCN, Brandon J. Manley, MD @MoffittNews, @larcg_org
0
1
5
@VikasSinghMD
Vikas Singh, MD, MBA, FACP
2 years
This is truly groundbreaking..!! Congratulations @DrChoueiri. @DanaFarber_GU #GU24 @OncoAlert @urotoday @GUOncologyNow
@DrChoueiri
Toni Choueiri, MD
2 years
51 years in the making till #GU24. OS benefit in adjuvant Renal Cancer is finally here. #KYN564
0
5
9
@larcg_org
LARCG
2 years
Un cambio de paradigma en America Latina, desde la convicción y el compromiso. @larcg_org
0
1
6
@larcg_org
LARCG
2 years
0
7
21
@CCollinsKCC
Christine Collins
2 years
Day 3 #IKCC2023 Dynamic presentation panel on Metastatic Disease. Dr Matias Chacon (AR), Dr Diego Abreu (UY) *LARCG, Dr Eric Jonasch (US) & patient Jin Young Paik (South Korea) - Moderator Radha Chitale. @IKCCorg @KidneyCancer_Ca @CancerduRein (*Latin America Renal Cancer Group)
0
4
6
@larcg_org
LARCG
2 years
It was an honor to have participated on behalf of the LARCG in the IKCC Global Kidney Cancer https://t.co/zgPdbUl7qA, where many organizations work with a clear vision have a multidisciplinary impact on all aspects of the RCC. @IKCCorg, @advocatekidneys. @StenioZequi. ⁩
0
0
1
@kcCURE
KCCure
3 years
#AUA23 poster prize winner! Congratulations to the patients who shared their voice and made this presentation possible. Understanding patient perceptions of risk vs benefit in adjuvant therapy is crucial to improving care and outcomes.
3
14
44
@larcg_org
LARCG
3 years
Grateful to the LARCG members, for making the collaborative group stronger each year. The 2023 annual meeting at AUA came with very good news of collaboration with @KidneyCancer and various publications coming soon. @StenioZequi,@DrFRodriguezCov, @autran_anamaria,@AlbertoBreda1
0
6
13
@larcg_org
LARCG
3 years
Excellent summary of the short and prosperous life of our LARCG. Looking back we can see the enormous effort that should fill us with pride. Thanks to everyone and especially to Dr. Spiess for this wonderful opportunity. @StenioZequi,@SpiessPhilippe, @nolazcomd,@autran_anamaria
0
2
4
@larcg_org
LARCG
3 years
Excellent summary of the short and prosperous life of our LARCG. Looking back we can see the enormous effort that should fill us with pride. Thanks to everyone and especially to Dr. Spiess for this wonderful opportunity. @StenioZequi,@SpiessPhilippe, @nolazcomd,@autran_anamaria
0
2
4
@StenioZequi
Stenio Zequi
3 years
Hoje com muito orgulho Apresentado a aula “ Contextualizado a lá Nefrectomia Citorreductora”, durante el LXXIII Congresso Nacional de Urologia da Sociedade Mexicana Urologia em Boca del Rio Vera Cruz -México. Gracias a lá @UrologosJovenes @smumexico @larcg_org @acccancercenter
1
2
6
@EUplatinum
European Urology
3 years
New Platinum Priority Editorial from @milanhoraplzen @AlbigesL et al. @Uroweb Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View https://t.co/XtYmnwIOFj
0
23
42
@IKCCorg
IKCC Kidney Cancer
4 years
We’re joining #kidneycancer groups around the world to celebrate World Kidney Cancer Day on June 16. Studies show many #kidneycancer patients are not aware of the treatment options that may be available to them. Join us to talk about ‘treatment options’. #WKCD2022
0
4
8